Marc A. Cohen

Insider Reports History

Identity 1 fact
Location
Arlington, VA
SEC filing record 1 fact
SEC signature
/s/ Jolie M. Siegel, Attorney-in-Fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Marc A. Cohen:

Form 4 holding Director

C4 Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
23,500
Estimated value
Report date
22 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Frequency Therapeutics, Inc.

Security class
Stock Option
Shares / value
14,846
Estimated value
Report date
21 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Marc A. Cohen

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .